|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clini. 65:87–108. 2015. View Article : Google Scholar
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abnet CC, Arnold M and Wei WQ:
Epidemiology of esophageal squamous cell carcinoma.
Gastroenterology. 154:360–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clini. 63:11–30. 2013. View Article : Google Scholar
|
|
5
|
Kim T, Grobmyer SR, Smith R, Ben-David K,
Ang D, Vogel SB and Hochwald SN: Esophageal cancer-The five year
survivors. J Surg Oncol. 103:179–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmittgen TD: Regulation of microRNA
processing in development, differentiation and cancer. J Cell Mol
Med. 12:1811–1819. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hiyoshi Y, Kamohara H, Karashima R, Sato
N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M
and Baba H: MicroRNA-21 regulates the proliferation and invasion in
esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kurashige J, Watanabe M, Iwatsuki M,
Kinoshita K, Saito S, Hiyoshi Y, Kamohara H, Baba Y, Mimori K and
Baba H: Overexpression of microRNA-223 regulates the ubiquitin
ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer.
106:182–188. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kimura S, Naganuma S, Susuki D, Hirono Y,
Yamaguchi A, Fujieda S, Sano K and Itoh H: Expression of microRNAs
in squamous cell carcinoma of human head and neck and the
esophagus: miR-205 and miR-21 are specific markers for HNSCC and
ESCC. Oncol Rep. 23:1625–1633. 2010.PubMed/NCBI
|
|
12
|
Gopalan V, Islam F, Pillai S, Tang JC,
Tong DK, Law S, Chan KW and Lam AK: Overexpression of microRNA-1288
in oesophageal squamous cell carcinoma. Exp Cell Res. 348:146–154.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun J, Song K, Feng X and Gao S:
MicroRNA-367 is a potential diagnostic biomarker for patients with
esophageal squamous cell carcinoma. Biochem Biophys Res Commun.
473:363–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang M, Wang L, Zhang M, Li X, Zhu Z and
Wang H: MiR-214 inhibits the proliferation and invasion of
esophageal squamous cell carcinoma cells by targeting CDC25B.
Biomed Pharmacother. 95:1678–1683. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dai C, Xie Y, Zhuang X and Yuan Z: MiR-206
inhibits epithelial ovarian cancer cells growth and invasion via
blocking c-Met/AKT/mTOR signaling pathway. Biomed Pharmacother.
104:763–770. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang WL, Lv W, Sun SZ and Zhang JH:
miR-206 inhibits metastasis-relevant traits by degrading MRTF-A in
anaplastic thyroid cancer. Int J Oncol. 47:133–142. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao QF, Qiu JC, Huang XH, Xu YM, Li SQ,
Sun F, Zhang J, Yang WM, Min QH, Jiang YH, et al: The predictive
and prognostic role of a novel ADS score in esophageal squamous
cell carcinoma patients undergoing esophagectomy. Cancer Cell Int.
18:1532018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA. org resource: targets and expression.
Nucleic Acids Res. 36:D149–D153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saito T and Sætrom P: MicroRNAs-Targeting
and target prediction. N Biotechnol. 27:243–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Osman A and Fälker K: Characterization of
human platelet microRNA by quantitative PCR coupled with an
annotation network for predicted target genes. Platelets.
22:433–441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding W, Ren J, Ren H and Wang D: Long
noncoding RNA HOTAIR modulates MiR-206-mediated Bcl-w signaling to
facilitate cell proliferation in breast cancer. Sci Rep.
7:172612017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan X, Wang Z, Wan B and Zheng Z:
MicroRNA-206 inhibits the viability and migration of
medulloblastoma cells by targeting LIM and SH3 protein 1. Exp Ther
Med. 14:3894–3900. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu F, Zhao X, Qian Y, Zhang J, Zhang Y
and Yin R: MiR-206 inhibits head and neck squamous cell carcinoma
cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
Biomed Pharmacother. 96:229–237. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Organ SL and Tsao MS: An overview of the
c-MET signaling pathway. Ther Adv Med Oncol. 3:S7–S19. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pandima Devi K, Rajavel T, Daglia M,
Nabavi SF, Bishayee A and Nabavi SM: Targeting miRNAs by
polyphenols: Novel therapeutic strategy for cancer. Semin Cancer
Biol. 46:146–157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deng X, Zheng H, Li D, Xue Y, Wang Q, Yan
S, Zhu Y and Deng M: MicroRNA-34a regulates proliferation and
apoptosis of gastric cancer cells by targeting silent information
regulator 1. Exp Ther Med. 15:3705–3714. 2018.PubMed/NCBI
|
|
30
|
Liu W, Li M, Chen X, Zhu S, Shi H, Zhang
D, Cheng C and Li B: MicroRNA-1 suppresses proliferation, migration
and invasion by targeting Notch2 in esophageal squamous cell
carcinoma. Sci Rep. 8:51832018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li F, Lv JH, Liang L, Wang JC, Li CR, Sun
L and Li T: Downregulation of microRNA-21 inhibited
radiation-resistance of esophageal squamous cell carcinoma. Cancer
Cell Int. 18:392018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Hong F and Yu Z: Decreased
expression of microRNA-206 in breast cancer and its association
with disease characteristics and patient survival. J Int Med Res.
41:596–602. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pang C, Huang G, Luo K, Dong Y, He F, Du
G, Xiao M and Cai W: miR-206 inhibits the growth of hepatocellular
carcinoma cells via targeting CDK9. Cancer Med. 6:2398–2409. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiao H, Xiao W, Cao J, Li H, Guan W, Guo
X, Chen K, Zheng T, Ye Z, Wang J and Xu H: miR-206 functions as a
novel cell cycle regulator and tumor suppressor in clear-cell renal
cell carcinoma. Cancer Lett. 374:107–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang J and Babic A: Regulation of the MET
oncogene: Molecular mechanisms. Carcinogenesis. 37:345–355. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Marano L, Chiari R, Fabozzi A, De Vita F,
Boccardi V, Roviello G, Petrioli R, Marrelli D, Roviello F and
Patriti A: c-Met targeting in advanced gastric cancer: An open
challenge. Cancer Lett. 365:30–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ho-Yen CM, Jones JL and Kermorgant S: The
clinical and functional significance of c-Met in breast cancer: A
review. Breast Cancer Res. 17:522015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bleau AM, Redrado M, Nistal-Villan E,
Villalba M, Exposito F, Redin E, de Aberasturi AL, Larzabal L,
Freire J, Gomez-Roman J and Calvo A: miR-146a targets c-met and
abolishes colorectal cancer liver metastasis. Cancer Lett.
414:257–267. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Korhan P, Erdal E and Atabey N:
MiR-181a-5p is downregulated in hepatocellular carcinoma and
suppresses motility, invasion and branching-morphogenesis by
directly targeting c-Met. Biochem Biophys Res Commun.
450:1304–1312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hu Z, Lin Y, Chen H, Mao Y, Wu J, Zhu Y,
Xu X, Xu X, Li S, Zheng X and Xie L: MicroRNA-101 suppresses
motility of bladder cancer cells by targeting c-Met. Biochem
Biophys Res Commun. 435:82–87. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen QY, Jiao DM, Wu YQ, Chen J, Wang J,
Tang XL, Mou H, Hu HZ, Song J, Yan J, et al: MiR-206 inhibits
HGF-induced epithelial-mesenchymal transition and angiogenesis in
non-small cell lung cancer via c-Met/PI3k/Akt/mTOR pathway.
Oncotarget. 7:18247–18261. 2016.PubMed/NCBI
|
|
42
|
Chen QY, Jiao DM, Wang J, Hu H, Tang X,
Chen J, Mou H and Lu W: miR-206 regulates cisplatin resistance and
EMT in human lung adenocarcinoma cells partly by targeting MET.
Oncotarget. 7:24510–24526. 2016.PubMed/NCBI
|
|
43
|
Yao Y, Dou C, Lu Z, Zheng X and Liu Q:
MACC1 suppresses cell apoptosis in hepatocellular carcinoma by
targeting the HGF/c-MET/AKT pathway. Cell Physiol Biochem.
35:983–996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Trovato M, Torre ML, Ragonese M, Simone A,
Scarfì R, Barresi V, Giuffrè G, Benvenga S, Angileri FF, Tuccari G,
et al: HGF/c-met system targeting PI3K/AKT and
STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: An
immunohistochemical characterization in view of targeted therapies.
Endocrine. 44:735–743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jiang J, Feng X, Zhou W, Wu Y and Yang Y:
MiR-128 reverses the gefitinib resistance of the lung cancer stem
cells by inhibiting the c-met/PI3K/AKT pathway. Oncotarget.
7:73188–73199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li B, Tsao SW, Li YY, Wang X, Ling MT,
Wong YC, He QY and Cheung AL: Id-1 promotes tumorigenicity and
metastasis of human esophageal cancer cells through activation of
PI3K/AKT signaling pathway. Int J Cancer. 125:2576–2585. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yoshioka A, Miyata H, Doki Y, Yasuda T,
Yamasaki M, Motoori M, Okada K, Matsuyama J, Makari Y, Sohma I, et
al: The activation of Akt during preoperative chemotherapy for
esophageal cancer correlates with poor prognosis. Oncol Rep.
19:1099–1107. 2008.PubMed/NCBI
|
|
48
|
Zhao H, Yang J, Fan T, Li S and Ren X:
RhoE functions as a tumor suppressor in esophageal squamous cell
carcinoma and modulates the PTEN/PI3K/Akt signaling pathway. Tumour
Biol. 33:1363–1374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu M, Hu Y, Zhang MF, Luo KJ, Xie XY, Wen
J, Fu JH and Yang H: MMP1 promotes tumor growth and metastasis in
esophageal squamous cell carcinoma. Cancer Lett. 377:97–104. 2016.
View Article : Google Scholar : PubMed/NCBI
|
